US judge overturns Eli Lilly's $176.5 million loss in Teva patent case

Drugmaker Eli Lilly (LLY.N) convinced a federal judge in Massachusetts on Tuesday to overturn a $176.5 million jury verdict for Teva Pharmaceutical (TEVA.TA) that found Lilly's migraine drug Emgality infringed three patents related to Teva's rival drug Ajovy.